Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great report my ass...
It's just been proven that this company has no IP - it is a worthless scam.
A quote from the replied to post...
The unique proprietary technology found in each Dalrada machine provides decarbonized heating and cooling capabilities suitable for a broad range of industries and applications, including hotels and resorts, commercial and office buildings, hospitals and medical facilities, schools and universities, large data centers, and more.
I wonder if it looked like this?
https://dalradaclimatetech.com/wp-content/uploads/2024/04/DCT_MM1031US-EN_V02_product-catalog.pdf
Or this?
Lync by Watts heat pump...
https://www.lyncbywatts.com/products/heat-pumps
Link to original:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=69486867
nodummy
Re: nodummy post# 11543
Thursday, December 01, 2011 3:50:24 AM
Post# 18772 of 220331
STTN some research inspired by the filing of the last 10Q on November 21, 2011
The stock started to plummet the day before the 10Q filing (maybe some insiders with advanced knowledge that the 10Q was going to be brutal decided they better start getting out early?)
https://investorshub.advfn.com/uimage/uploads/2011/12/1/keizrScreen_shot_2011-12-01_at_1.45.48_AM.png
-----
So what was in this 10Q?
Before we get to that a quick rundown on the events that have happened over the past few months:
-----
Starting shortly after the former Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer and founder of the company, Perry Law, tendered his resignation from his last remaining position of Director effective immediately on June 3, 2011 things have taken a very bad turn for the worse.
-----
On June 9, 2011, Brian Bonar signed a toxic financing agreement with La Jolla which included a $500,000 debenture agreement and the right for La Jolla to purchase up to $5,000,000 worth of stock at 80% below the market price. To date this agreement has not been executed.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=7997447
On June 15, 2011, Brian Bonar issued himself 21,897,999 shares at no cost. According to the recently filed 10Q those shares were issued for $218,979 in compensation owed. On June 15, 2011, STTN closed at $.071/share making the actual value of those shares $1,554,757.93.
http://www.sec.gov/Archives/edgar/data/947011/000106299311002630/xslF345X03/form4a.xml
On June 17, 2011, Brian Bonar issued to his Director, Owen Naccarato, 3,000,000 shares at no cost for $225,000 in compensation owed.
http://www.sec.gov/Archives/edgar/data/947011/000106299311002672/xslF345X03/form4.xml
On July 29, 2011, Brian Bonar and Owen Naccarato met at the Rancho Bernardo Inn and used their 24,897,999 shares to elect themselves as the new Directors for the STTN shell.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8069037
On October 17, 2011, Brian Bonar brought his son, Colin Niven Bonar (aka C. Niven Bonar aka C N Bonar), into the picture by purchasing a group of companies which were all wholly owned subsidiaries of American Marine LLC, a company controlled by both Brian Bonar and C. Niven Bonar, for $50,000 and a $500,000 debt Note.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8194094
Solvis Medical Group consists of three revoked Nevada entities
Solvis Medical Inc and Solvis Medical Staffing Inc and Solvis Physical Therapy Inc all with Eric Gaer and Robert Dietrich listed as officers.
Former chairman of the Solvis Medical Group is Brian Bonar.
American Marine LLC is controlled by both Brian Bonar and C. Niven Bonar
http://www.corporationwiki.com/California/Escondido/american-marine-llc/47532519.aspx
Owen Naccarato (STTN Director) served as the legal counsel for the signed agreement between father and son.
C. Niven Bonar and Brian Bonar were previously linked with Dalrada Financial Corp (DFCO). Both C. Niven Bonar and Brian Bonar's daughter, Pauline Bonar, were initial shareholders in Dalrada Financial Corp back in 1999 while Brian Bonar was the CEO. Not so coincidentally Owen Naccarato was and still is the legal counsel for Bonar linked Delrada Financial Corp.
http://www.otcmarkets.com/stock/DFCO/company-info
The Bonar, Bonar, Naccarato connections don't end there.
The three can be linked to Allegiant Professional Business Services, Inc. (APRO)
Where daddy Bonar served as a Director and president, son Bonar served as the COO, and Naccarato once against served as legal counsel:
http://www.otcmarkets.com/stock/APRO/company-info
http://investing.businessweek.com/research/stocks/people/people.asp?ticker=APRO:US
APRO was (I used past tense because that company is basically dead now) a PEO company just like STTN is now.
APRO even uses the same address as STTN
11838 Bernardo Plaza Ct.
Suite 240
San Diego, CA 92128
Which is in shouting distance from American Marine LLC
11838 Bernardo Plaza Ct
Suite 210
San Diego, CA 92128
And is within walking distance from Dalada Financial Corp
11956 Bernardo Plaza Drive
#516
San Diego, CA 92128
John Capezzuto who works with Brian Bonar with APRO also worked with Brian Bonar with scam company Warning Management Services Inc. (WNMI) which was revoked by the SEC on May 22, 2009
http://www.sec.gov/litigation/admin/2009/34-59968.pdf
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=64388493
Legal counsel for scam company WNMI was Owen Naccarato.
Are you beginning to wonder if Brian Bonar always uses Owen Naccarato for a reason?
Here is a list of companies for which Owen Naccarato currently provides legal services:
http://www.otcmarkets.com/service-provider/Naccarato-&-Associates?id=2062&b=n&filterOn=3
Allegiant Professional Business Services, Inc. (APRO)
Com-Guard.com, Inc. (CGUD)
Dalrada Financial Corp. (DFCO)
Diverse Media Group, Inc. (DVME)
DPOLLUTION International Inc. (RMGX)
eMamba International Corp. (EMBA)
Family Room Entertainment Corp. (FMYR)
Genco Corp. (GNCC)
Global Digital Solutions, Inc. (GDSI)
Icon Media Holdings, Inc. (ICNM)
ITonis, Inc. (ITNS)
Lexico Resources International, Inc. (LXXI)
Markray Corp. (RVBR)
Quad Energy Corp (CDID)
Ree International, Inc. (REEI)
Smart-Tek Solutions, Inc. (STTN)
South Shore Resources, Inc. (SSHO)
TapSlide, Inc. (TSLI)
Velocity Energy Inc. (VCYE)
This link draws some interesting past connections between Corey Ribotsky and many companies that used Owen Naccarato as legal counsel
http://www.offshorealert.com/WorkArea/threadeddisc/print_thread.aspx?id=60&g=posts&t=37726
---------------------
I got side tracked though back to the 10Q
Then on November 21, 2011, the STTN 10Q for the 3rd quarter came out and it was ugly.
Cash on September 30, 2011 - $270,048
Cash on June 30, 2011 - $882,069
STTN lost $612,021 in cash during the 3rd quarter
Accounts payable and accrued liabilities on September 30, 2011 - $8,384,307
Accounts payable and accrued liabilities on June 30, 2011 - $3,256,689
STTN added $5,127,619 in accounts payable and accrued liabilities during the 3rd quarter
The accounts payable and accrued liabilities for the 2nd quarter was only $82,477
$5,127,619 is $2,129,070 more than STTN had in accounts payable and accrued liabilities for its entire existence from 1995 - through the 2nd quarter of 2011.
Why the $5,127,619 in accounts payable and accrued liabilities all in just a 3 month period? Who is all that money owed to?
Gross profit on September 30, 2011 (for 3rd quarter) - negative $155,177
Gross profit on June 30, 2011 (for 2nd quarter) - $1,685,183
STTN went from a profitable business to a company with a failing business. The cost of revenue for the 3rd quarter of 2011 was higher than the revenues themselves. They would have been better off not doing business in the 3rd quarter.
Subtract away the operation costs/expenses and
Overall operating loss on September 30, 2011 (for 3rd quarter) - $2,963,852
Overall operating loss on June 30, 2011 (for 2nd quarter) - $599,161
STTN's operating losses increased by $2,364,691.
During the 1st quarter of 2011 (the period ending March 31, 2011), STTN didn't have an operation loss. They had an operating gain of $363,354 after subtracting away all the costs of operations from the revenues for the quarter. It is obvious the direction that STTN is headed, and it is not good.
A further break down of the Selling, general and administrative expenses helps partially explain why STTN is headed down the toilet.
Salaries & Related Expense
1st quarter - $311,430
2nd quarter - $582,969
3rd quarter - $553,404
Consulting
1st quarter - $220,366
2nd quarter - $158,823
3rd quarter - $353,624
Commissions
1st quarter - $177,223
2nd quarter - $269,583
3rd quarter - $633,742
Outside Services
1st quarter - $31,688
2nd quarter - $62,403
3rd quarter - $211,287
Overall Selling, General, and Administrative Expenses
1st quarter - $1,272,515
2nd quarter - $1,685,183
3rd quarter - $1,997,439
Since revenues dropped by 28% from the 2nd quarter to the 3rd quarter why did commissions increase by 235% during that same stretch?
----------------
The most disturbing parts of the recent STTN filings:
#1) Brian Bonar paying himself $1,554,757.93 in shares for a $218,979 balance that was owed to him then writing off the payment in the books as a $218,979 stock expense.
#2) Brian Bonar issuing himself and his son a $500,000 debt Note for a group of revoked business entities.
#3) The $5,127,619 in accounts payable accrued during the 3rd quarter alone. Who is all that money owed to?
#4) STTN went from a positive balance sheet at the end of the 1st quarter to a failing business whose revenues cost more than what they make.
#5) The past connections and histories of the main players involved in STTN.
I am "MsNelson" - and I am a LWLG stockholder, nothing more.
He is doing this for the purpose of harassment because I am posting the truth about Brian Bonar, a crook who's been running pump and dumps since the '80s.
https://investorshub.advfn.com/Dalrada-Financial-Corp-DFCO-2545
Brian Bonar runs with and probably is the head of a cabal of crooks.
Wallace and MacLeod were part of that cabal... they destroyed this CEO and kept a good product off of the market.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=123839668
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=82739671&txt2find=BONAR
DFCO's price increase today was pure paint...
date, time, last,bid, ask ,volume
05/30/24 12:24:42 0.189 0.1561 0.189 2,500
05/30/24 12:24:37 0.189 0.00 0.00 625
05/30/24 12:24:22 0.189 0.00 0.00 625
05/30/24 12:24:07 0.189 0.00 0.00 625
05/30/24 12:19:58 0.1625 0.156 0.189 12,249
05/30/24 12:19:52 0.1626 0.156 0.1626 1,000
05/30/24 12:19:42 0.1626 0.156 0.189 5,031
05/30/24 12:16:30 0.1626 0.1626 0.189 12,500
05/29/24 15:51:51 0.1625 0.1611 0.189 1,750
05/28/24 15:48:05 0.17 0.165 0.189 6,200
05/28/24 15:48:03 0.189 0.165 0.17 75
05/28/24 15:40:42 0.189 0.1653 0.189 1,000
05/28/24 15:31:16 0.179 0.1651 0.189 250
05/28/24 13:33:11 0.179 0.158 0.189 250
05/28/24 11:48:09 0.173 0.157 0.189 250
05/28/24 11:42:10 0.18 0.157 0.189 15,000
05/28/24 11:41:51 0.1789 0.1601 0.18 7,670
05/28/24 11:29:57 0.1701 0.1601 0.18 2,500
05/28/24 11:07:11 0.18 0.1601 0.18 500
05/28/24 10:46:46 0.1789 0.1601 0.18 500
05/24/24 12:24:31 0.1757 0.165 0.179 1
05/24/24 12:21:46 0.1757 0.168 0.179 1,500
05/24/24 12:18:43 0.165 0.165 0.179 4,100
05/24/24 12:13:55 0.165 0.165 0.179 5,000
05/24/24 12:03:13 0.151 0.151 0.1699 20,740
05/24/24 12:03:12 0.1531 0.153 0.1699 5,000
05/24/24 12:03:07 0.1555 0.1531 0.1699 10,000
05/24/24 12:02:44 0.156 0.156 0.1799 9,100
05/24/24 12:02:42 0.156 0.156 0.1799 5,000
05/24/24 12:02:32 0.1625 0.156 0.1799 8,500
05/24/24 12:02:30 0.17 0.1625 0.18 5,000
05/24/24 12:02:20 0.1626 0.1625 0.18 17,160
05/24/24 12:02:11 0.171 0.171 0.18 4,500
05/24/24 10:15:58 0.18 0.17 0.18 300
05/24/24 10:15:57 0.175 0.17 0.18 500
05/24/24 09:58:31 0.171 0.17 0.18 500
05/24/24 09:58:12 0.1755 0.171 0.18 500
Here's some info on the DCE - it's the same as this one:
North America’s First Commercial CO2 Heat Pump
Powered by natural refrigerant R744, better known as refrigerant-grade CO2, Lync’s Aegis heat pumps are one of the cleanest, most efficient and environmentally friendly ways to heat domestic water. R744 is non-toxic, non-flammable, has an ODP (Ozone Depletion Potential) of zero and a low GWP (Global Warming Potential) of one. R744 also outperforms other common refrigerants, like R134a and R410a, making Aegis a better, longer-lasting and more sustainable solution.
Additional Features
Cool recovery option provides simultaneous production of cold water along with hot water, further increasing COP
The heat pump can be remotely controlled through the building automation system (BAS) allowing users to check the status of the unit real time, record operational data, check for faults with alarms and warnings, change set point and operating modes and much more
Fan coil coating available for coastal areas
Advanced defrost cycle with electric coil eliminates the need to reverse operation to defrost
Ideal for new and retrofit, multifamily, gyms, industrial, hospitality, education and healthcare
REMOTE MONITORING
Remote Monitoring allows the remote connection to each unit in order to check real-time
status, as well as view or download the recorded data, or send commands to the controller
(change set-point, operating mode etc.)
• The graphical user interface ensures fast and easy data analysis.
• All alarms and warnings are logged, with both alarm start and alarm reset(date/time)
Telling the truth and posting facts about BONAR....
... IS NOT SLANDER!!!!!
Holy Mackeral!!!!
Look at all of the heat pumps on the market...
https://www.google.com/search?rlz=1C1ONGR_enUS1087US1087&sca_esv=c305179642ddeb9a&sca_upv=1&cs=0&biw=1837&bih=965&tbm=shop&sxsrf=ADLYWIIiodXbsNuhpmyhA0Ujg55nwH-HxA:1717070356979&q=gpg+approved+%22heat+pumps%22&tbs=mr:1,pdtr0:2657032%7C2657034&sa=X&ved=0ahUKEwi27rnFqbWGAxUjGDQIHXIiB7QQwQkIiRooAA
Check it out -
DFCO heat pump...
https://dalradaclimatetech.com/wp-content/uploads/2024/04/DCT_MM1031US-EN_V02_product-catalog.pdf
Lync by Watts heat pump...
https://www.lyncbywatts.com/products/heat-pumps
I'll connect the dots for anyone who can't.
DFCO has no IP - no unique product.
The replied to post made exactly one year ago is B.S.
LOL!!!!
They don't use Co2 as there refrigerant. Does not save you up to 80% on your heat pumps. Do your research before you say all these negative things
JUST GOOGLE IT!!!!!
https://www.google.com/search?q=what+companys+use+heat+pump+co2+refrigerant&sca_esv=591706057&rlz=1C1ONGR_enUS1087US1087
Residential CO2 Heat Pump - Denso-am.eu
denso-am.eu
https://www.denso-am.eu › other › residential-co2-hea...
DENSO first introduced CO2 refrigerant to its Air to Water Heat Pumps in 2001, in Japan. Known as 'Eco-Cute', the product's improved energy efficiency meant ...
A Heat Pump Using Carbon Dioxide as the Refrigerant
BuildingGreen
https://www.buildinggreen.com › blog › heat-pump-u...
Aug 28, 2013 — Mayekawa offers three different CO2 heat pumps, the EcoCute water-to-water heat pump, the Unimo air-to-water heat pump and the Sirocco water-to- ...
SANCO2 Heat Pump Water Heaters
Small Planet Supply
https://www.smallplanetsupply.com › sanc02
The SANCO2™ works just like a conventional heat pump, except that it uses CO2 as a refrigerant. Due to the unique properties of CO2, the SANCO2 operates very ...
?The Clear Path To Net Zero... · ?Efficient Operation: How The... · ?The Sanco2 Uses Co2 As A...
Simcoe Air Source CO2 Heat Pump
Transom Corporation
https://www.transomcorporation.com › products › sim...
CO2 Heat Pumps – Simcoe ... The Simcoe Air Source Heat Pump is designed with environmentally friendly CO2 refrigerant. This means that it has an Ozone Depletion ...
?CO2 Heat Pumps – Simcoe · ?Domestic Hot Water Projects... · ?Capacity Control
Mayekawa Unveils CO2 Heat Pump for U.S. Residential ...
R744
https://r744.com › mayekawa-unveils-co2-heat-pump-...
Apr 11, 2023 — Japanese OEM Mayekawa has announced it will be launching its Unimo AW CO2 (R744) air-source commercial heat pump for domestic hot water ...
Residential CO2 Heat Pump - DENSO
denso.ae
https://denso.ae › other › residential-co2-heat-pump
Typically heat pumps use a synthetic refrigerant gas such as R410A, which has a GWP of 2088. This number indicates that, when emitted into the air, its impact ...
Why CO2 Heat Pumps Are The Future Of Cooling
undecidedmf.com
https://undecidedmf.com › why-co2-heat-pumps-are-t...
Sep 12, 2023 — In the early 2000s, companies like Nihon Itomic developed CO2 tech for ... A Heat Pump Using Carbon Dioxide as the Refrigerant ↩︎; Heat Pump ...
CO2 Heat Pumps - Made in the UK - Clade Engineering
Clade Engineering
https://clade-es.com › heat-pumps › about-co2-heat-p...
what companies use heat pump co2 refrigerant from clade-es.com
A CO2 heat pump uses carbon dioxide as a refrigerant. Carbon dioxide is a naturally occurring gas, and it has a very low boiling point. This makes it ideal for ...
?Browse Co2 Heat Pumps · ?What Are Co2 Heat Pumps? · ?Co2 Heat Pump Services
Lync Says Its CO2 Hot-Water Heat Pumps in Use Across ...
R744
https://r744.com › lync-says-its-co2-hot-water-heat-pu...
what companies use heat pump co2 refrigerant from r744.com
Apr 18, 2023 — Texas (U.S.)-based manufacturer Lync, part of Watts Water Technologies, has said its Aegis CO2 (R744) hot-water heat pumps are now in use ...
Related searches
DFCO has no unique IP for their heat pumps.
Dalrada Home’s Heat Pumps are the Next Generation of Heating and Cooling
Our new domestic heat pump represents the convergence of high efficiency, global market reach, pioneering technology, and comprehensive R&D efforts. These elements, combined with our extensive network of partners and a deep understanding of the needs of different markets, make our heat pump not only easy to sell but also a preferred choice for customers around the world.
This is cutting edge technology that is being used throughout Europe, but the US is a completely untapped market. By bringing this as a ‘new’ technology to the US market, we will be able to establish ourselves as an authority in this space.
Heat pumps as an energy-efficient solution to conventional heating are improving the impact of heating on our environment. This article puts the spotlight on three large heat pump producers in the United States, shedding light on their specialties and locations.
1. Carrier Corporation
Carrier is a global leading provider of safe, sustainable, and healthy building and cold chain solutions. The Florida based company manufactures ventilation, heating, and air conditioning systems. In 1902 Willis Carrier, the company’s founder, developed the first modern air conditioning system. Carries has continued to build on that legacy and keeps innovating heating and cooling solutions, with heat pumps being one of them. In the beginning of this year Carrier released a new heat pump series that is compliant with the 2023 Department of Energy minimum efficiency requirements. Carrier has more than 75 industry-leading brands, including Bryant, CIAT, NORESCO, Logic and Heil.
2. Rheem Manufacturing
Rheem Manufacturing is an Atlanta based member of AHRI (Air-Conditioning, Heating, and Refrigeration Institute) and a leading manufacturer of high-quality, responsible, environmentally, and innovative water heaters, furnaces, air conditioners, pool heaters, and HVAC systems for residential and commercial applications. Their heat pumps can be used in commercial and residential settings and offer energy efficiency.
3. Lennox International Inc.
Lennox International Inc. is a Dallas based global provider of climate control solutions for the heating, air conditioning and refrigeration markets and is a leader in energy-efficient climate-control solutions, including heat pumps. The company offers heat pumps with innovative technological features, owning all its parts. Lennox has manufacturing and distribution facilities across North America.
Does batty boots know how many accounts Brian Bonar has?
Manipulative cabal balancing the books because of T-1.
My best guess...
Unfortunately the collusive wash trading continues. If this pattern becomes the new normal it will be proof of collusion.
DFCO - junk stock - no interest.
05/28/24 11:48:09 0.173 0.157 0.189 250
05/28/24 11:42:10 0.18 0.157 0.189 15,000
05/28/24 11:41:51 0.1789 0.1601 0.18 7,670
05/28/24 11:29:57 0.1701 0.1601 0.18 2,500
05/28/24 11:07:11 0.18 0.1601 0.18 500
05/28/24 10:46:46 0.1789 0.1601 0.18 500
05/24/24 12:24:31 0.1757 0.165 0.179 1
05/24/24 12:21:46 0.1757 0.168 0.179 1,500
05/24/24 12:18:43 0.165 0.165 0.179 4,100
05/24/24 12:13:55 0.165 0.165 0.179 5,000
05/24/24 12:03:13 0.151 0.151 0.1699 20,740
05/24/24 12:03:12 0.1531 0.153 0.1699 5,000
05/24/24 12:03:07 0.1555 0.1531 0.1699 10,000
05/24/24 12:02:44 0.156 0.156 0.1799 9,100
05/24/24 12:02:42 0.156 0.156 0.1799 5,000
05/24/24 12:02:32 0.1625 0.156 0.1799 8,500
05/24/24 12:02:30 0.17 0.1625 0.18 5,000
05/24/24 12:02:20 0.1626 0.1625 0.18 17,160
05/24/24 12:02:11 0.171 0.171 0.18 4,500
05/24/24 10:15:58 0.18 0.17 0.18 300
05/24/24 10:15:57 0.175 0.17 0.18 500
05/24/24 09:58:31 0.171 0.17 0.18 500
05/24/24 09:58:12 0.1755 0.171 0.18 500
MM's don't give a damn about a BONAR junk stock. They know it will always go to zero in the end...
Nope - it's the big money calling the shots - the management team is just a tool.
Zimmer still has a lot of active lawsuits. They don't want to show their cards and expose the fact that they knew they were poisoning people.
This is nuts.. took some nice profits and sold all but one share.
I still have one share but it's worth $9+ now.
Not going to be patient...
From my understanding of the science my combo flouroquinolone/covid mitochondrial dysfunction could be corrected by blarcamesine.
This is in addition to the conditions that gave been trialed.
If the MOA is correction of mitochondrial dysfunction how many have suffered and died since this announcement ?
Anavex Life Sciences Reports New Mechanism of Action Data Related to ANAVEX Compounds Targeting Sigma-1 Receptor
?
?
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, announced today the presentation of new mechanism of action data related to ANAVEX compounds targeting the sigma-1 receptor at the AD/PDTM 2017 Meeting.
Hall H et al presented preclinical data indicating that during pathological conditions, ANAVEX 3-71 demonstrated the formation of new synapses between neurons (synaptogenesis) without causing an abnormal increase in the number of astrocytes. In neurodegenerative diseases like Alzheimer’s and Parkinson’s disease, synaptogenesis is believed to be impaired.
Goguadze N et al presented preclinical data indicating that in addition to reducing oxidative stress, ANAVEX 2-73, ANAVEX 3-71 and ANAVEX 1-41 also demonstrated protective effects of the mitochondrial enzyme complexes I and IV during pathological conditions. The mitochondrial enzyme complex IV is directly involved in the synthesis of ATP, which provides energy within cells for metabolism. It is believed that energy production impairment and mitochondrial dysfunction play a role in the pathogenesis of neurodegenerative disorders and neurodevelopmental diseases.
“These new results provide converging evidence on mechanism of action as well as possible disease-modifying properties potentially by restoring homeostasis by means of the sigma-1 receptor agonists in our pipeline. This data also provides a foundation for our ongoing translational research efforts,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex.
Both data sets described that Aß1-42 (amyloid beta) significantly impairs biological function in the respective animal models and the observed regain of function confirmed the protective potential of ANAVEX sigma-1 receptor agonists against amyloid beta -induced toxicity. The former presentation further reported that although that the transgenic McGill rats had a very late stage of Alzheimer’s disease-like pathology (13 months of age), treatment with ANAVEX 3-71 fully reversed cognitive deficits, reduced amyloid pathology and also significantly reduced inflammation. Furthermore, the sustained recovery in cognition and pathophysiology observed following a month-long washout phase in advanced pathology (19 months of age) strongly suggests true disease-modifying properties of ANAVEX 3-71.
Another scam is to call clinically sound trials a "scam"....
Sounds like a personal problem:
I have been a complete advocate of tedpeele, his observations and insight.
So, writing fraudulent academic journals would also be a $30 billion dollar industry, wouldn't it?
Do you know how many times BONAR has crashed and burned a "public company" that he controlled in the last 50 years?
Can't give you an exact total but it was 100% of the public companies he controlled.
10,20, 30, 50??? My best guess is 20 plus, but I don't think there is anyone on this earth that has a worse personal track record of exploiting the market with "public" companies that are pure scams.
This is a junk stock.
BONAR has been a stock market con for close to 50 years.
What "isn't adding up" is the market as a whole.
It's always been over - influenced by big money, but now they have AI to control it.
Since I understand this I will simply hold.
28 minutes in... been there done that.
https://rumble.com/v4x22if-dr.-david-martin-major-intel-reveal.-covid-19-and-bio-weapon-biggest-crime-.html
I got sick, was discharged from hospital.
The next day I was sleeping in a recliner due to pulmonary issues.
I KNEW I was dying.
The only reason I am alive is because I realized that my pulse-ox readings improved after routine NAC supplementation. Internet inquiries told me that I couldn't O.D. on NAC. I went from 600 mg 3x per day to 1200 mg ever 2-3 hours.
This is the only reason I am alive, and speaking the Truth is my mission.
I realized that NAC was important. My family ordered a case of NAC from a wholesaler.
The NAC ban was criminal.
Is the U.S. medical system in failure mode?
In contrast, O2TODAY is a small, nimble company that was already a believer in masks before COVID-19, that was already targeting an increasing population and pollution in the world, particularly in Asian markets. They were passionate about their technology. They had experience in retail. They were able to take the concept of a mask and make it sexy and desirable. No large company had done that. And moreover, they had deep roots in the Asian
markets, including China. For those reasons, it seemed like the most exciting opportunity for us. Now, beyond O2TODAY, we're exploring other applications like automotive, HVAC filters, wound dressings, clothing, and much more. Thankfully, we were able to maintain our listing on NASDAQ in good standing without having to do a reverse split, that was sometimes necessary in
previous years, and we are proud to have avoided it. Our revenues last year were understandably down. As with any medical device-reliant company, uh, we sell to CTL Amedica, and elective spine surgeries were essentially stopped when the pandemic was in full swing. The good news is, those surgeries are coming back, there's pent up demand. We expect those revenues to increase this year. The more significant event in 2020 was the sale, albeit small, of the first nonmedical products in SINTX's history, and I am very proud of that. David?
Anti Air Pollution Mask/Adjustable Straps/Allergy/Asthma/Travel/Cycling/Adult/Children/Men/Women/DIY/China/India (Medium/Large, Forest)
Brand: O2TODAY
5.0 5.0 out of 5 stars 2 ratings
Currently unavailable.
We don't know when or if this item will be back in stock.
Brand O2TODAY
“The AMA analysis shows that the shift away from independent practices is emblematic of the fiscal uncertainty and economic stress many physicians face due to statutory payment cuts in Medicare, rising practice costs, and intrusive administrative burdens,” AMA President Jesse M.Feb 1, 2024
In 2022, just half of knee replacements were performed in Canada in a timely manner
Percentage of procedures performed within the recommended time
ATLANTA, November 9, 2023 — A large study led by researchers at the American Cancer Society (ACS) shows there were approximately 100,000 fewer cancer surgeries performed during the first months of the pandemic, an estimated 40,000 fewer chemotherapy treatments initiated, and more than 55,000 fewer radiation treatments in the United States. Scientists attribute these significant deficits to a drop in the number of cancer diagnoses instead of changes in cancer treatment strategies. The study was published today in the Journal of the American Medical Association (JAMA) Oncology.
"These findings are very concerning,” said Dr. Leticia Nogueira, scientific director, health services research at the American Cancer Society and lead author of the study. “We knew the COVID-19 pandemic led to disruptions in access to healthcare, including cancer care, but we’re now beginning to see the full extent of the damage.”
We should all be afraid when the corporations controlling "healthcare" appear to be corrupt:
MAY 21,2024
Wyden Expands Big Pharma Tax Investigation with Pfizer Inquiry
New Letter to Pfizer CEO Builds on Three-Year Committee Investigation; The U.S. Is By Far Pfizer’s Largest Market, But Pfizer Regularly Books All Taxable Income Offshore
Washington, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., expanded his ongoing investigation into Big Pharma’s tax avoidance and profit shifting with a new letter sent on Monday to the CEO of Pfizer. An analysis by the Finance Committee of Pfizer’s SEC filings found that the company’s effective tax rate fell by 75 percent following the passage of the Trump tax law in 2017.
“While the exact methods by which Pfizer is able to pay such low tax rates are unclear, public records indicate that Pfizer books most of its earnings offshore and benefits from changes made by the Republican tax law that lowered tax rates on foreign profits of U.S. corporations … As a result of these arrangements, there is a substantial discrepancy between where Pfizer generates prescription drug sales and where Pfizer books earnings from those drug sales for tax purposes,” Senator Wyden wrote to Pfizer CEO Dr. Albert Bourla. “In 2014 and 2015 Pfizer paid effective tax rates of 25% and 22% respectively, but paid a paltry rate of just 5.4% in 2019 and 2020. Based on this analysis, the 2017 Republican tax law was likely a major contributor to Pfizer’s effective tax rate being slashed by over 75%. The American public deserves to understand how Pfizer, a multinational pharmaceutical corporation based in the U.S. with annual sales of at least $58 billion, paid a lower tax rate than a preschool teacher or a firefighter.”
Senator Wyden began his investigation of Big Pharma’s tax practices in 2021. In 2022, he released an interim report detailing how the pharmaceutical giant AbbVie used offshore subsidiaries to avoid paying billions of dollars in taxes on prescription drug sales. He released updated findings last year that included a JCT sector-wide analysis and information gathered in further investigations of four additional pharma giants: Abbott Laboratories, Amgen, Bristol Myers Squibb and Merck.
The new Pfizer letter is available below. A complete version with footnotes included is available here.
WOW - Pfizer's in deep doo doo...
MAY 21,2024
Wyden Expands Big Pharma Tax Investigation with Pfizer Inquiry
New Letter to Pfizer CEO Builds on Three-Year Committee Investigation; The U.S. Is By Far Pfizer’s Largest Market, But Pfizer Regularly Books All Taxable Income Offshore
Washington, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., expanded his ongoing investigation into Big Pharma’s tax avoidance and profit shifting with a new letter sent on Monday to the CEO of Pfizer. An analysis by the Finance Committee of Pfizer’s SEC filings found that the company’s effective tax rate fell by 75 percent following the passage of the Trump tax law in 2017.
“While the exact methods by which Pfizer is able to pay such low tax rates are unclear, public records indicate that Pfizer books most of its earnings offshore and benefits from changes made by the Republican tax law that lowered tax rates on foreign profits of U.S. corporations … As a result of these arrangements, there is a substantial discrepancy between where Pfizer generates prescription drug sales and where Pfizer books earnings from those drug sales for tax purposes,” Senator Wyden wrote to Pfizer CEO Dr. Albert Bourla. “In 2014 and 2015 Pfizer paid effective tax rates of 25% and 22% respectively, but paid a paltry rate of just 5.4% in 2019 and 2020. Based on this analysis, the 2017 Republican tax law was likely a major contributor to Pfizer’s effective tax rate being slashed by over 75%. The American public deserves to understand how Pfizer, a multinational pharmaceutical corporation based in the U.S. with annual sales of at least $58 billion, paid a lower tax rate than a preschool teacher or a firefighter.”
Senator Wyden began his investigation of Big Pharma’s tax practices in 2021. In 2022, he released an interim report detailing how the pharmaceutical giant AbbVie used offshore subsidiaries to avoid paying billions of dollars in taxes on prescription drug sales. He released updated findings last year that included a JCT sector-wide analysis and information gathered in further investigations of four additional pharma giants: Abbott Laboratories, Amgen, Bristol Myers Squibb and Merck.
The new Pfizer letter is available below. A complete version with footnotes included is available here.
Man, Zimmer even lied to me when I went to their website..
They said I could opt out of tracking on the site, but then the opt out screen did not give me that option.
I find your posts very enlightening, thank you.
It seems that Zimmer may have some ethics issues:
https://media.ca7.uscourts.gov/cgi-bin/rssExec.pl?Submit=Display&Path=Y2022/D03-21/C:21-1224:J:St__Eve:aut:T:fnOp:N:2848980:S:0#:~:text=Specifically%2C%20IMSS%20alleges%20Zimmer%20Biomet,to%20Mexican%20govern%2D%20ment%20officials.
Biomet Hip Implants
X-Ray of a Hip Joint Inflammation
The Biomet m2a magnum hip implant included metal-on-metal designs, which led to several complications, including metallosis.
Any individual who has received the Biomet metal-on-metal hip implant and is experiencing complications might be eligible to file a Biomet hip implant lawsuit.
There were more than 2,800 cases filed over defective hip implants, while the company settled most of the cases in 2014.
As of July 2019, Zimmer Biomet still has 190 pending lawsuits in the Multidistrict Litigation (MDL) in the federal court.
Getting a hip replacement surgery can be an overwhelming experience, but once done, you would expect to enjoy a healthy and active life. It would be devastating to continue experiencing pain, discomfort, and other issues after surgery. Unfortunately, these problems are usually caused by defective hip implants.
Biomet was one of the leading medical device companies, which was later bought by Zimmer in 2014. Zimmer Biomet became the country’s second-leading manufacturer of orthopedic implants and controlled 31% of the market by 2016. Biomet hip implants helped enhance the lives of numerous patients, but some of their products didn’t meet patient expectations, resulting in several lawsuits filed against the company.
Before these lawsuits, Biomet’s most popular products included the modular hip stem, g7 hip replacement, and Regenerex RingLoc+ Modular Acetabular System. However, the Biomet m2a magnum hip implant included metal-on-metal designs, which led to several complications, including metallosis.
Hundreds of complications were reported by patients and doctors who used the m2a magnum hip implant, but the devices were not recalled. Thousands of lawsuits were filed against Biomet, with the company eventually settling a vast number of these cases in 2014. However, there are still hundreds of cases pending.
If you or your loved one has undergone hip surgery using one of Biomet’s hip replacement implants and experienced complications, you may have the right to demand compensation for damages, losses, and for the suffering you endured.
The only way this scenario makes any sense is if some big cartel or corporation controls the majority of the stock.
I can't understand why there wouldn't be a few of these products in production.
Something really stinks here... and it isn't the tech.